---
document_datetime: 2023-12-04 19:37:01
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/kirsty-previously-kixelle-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: kirsty-previously-kixelle-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.6543787
conversion_datetime: 2025-12-30 01:10:05.468791
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Kirsty

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IAIN/0013            | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 30/11/2023                          |                                             | Annex II and PL                  |           |

2

A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The

CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| T/0012             | Transfer of Marketing Authorisation                                                                                                                                                                                                          | 03/08/2023   | 30/08/2023   | SmPC, Labelling and PL   |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-----------------------------------|
| IB/0009            | B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line)            | 14/07/2023   | n/a          |                          |                                   |
| IB/0011            | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                 | 07/07/2023   | n/a          |                          |                                   |
| N/0010             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                             | 17/05/2023   | 30/08/2023   | PL                       |                                   |
| PSUSA/1749/ 202209 | Periodic Safety Update EU Single assessment - insulin aspart                                                                                                                                                                                 | 14/04/2023   | n/a          |                          | PRAC Recommendation - maintenance |
| PSUSA/1749/ 202109 | Periodic Safety Update EU Single assessment - insulin aspart                                                                                                                                                                                 | 05/05/2022   | n/a          |                          | PRAC Recommendation - maintenance |
| IA/0007            | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 18/03/2022   | n/a          |                          |                                   |

<div style=\"page-break-after: always\"></div>

| II/0003/G   | This was an application for a group of variations. B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and biological/immunological medicinal products B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation                    | 13/01/2022   | n/a   |             |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------|
| IA/0006/G   | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                | 21/12/2021   | n/a   |             |
|             | This was an application for a group of variations. B.I.e.3 - Deletion of an approved change management protocol related to the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 06/12/2021   | n/a   | IAIN/0004/G |
| IB/0002     | B.IV.1.z - Change of a measuring or administration                                                                                                                                                                                                                                                                                                                                                        | 12/10/2021   | n/a   |             |

<div style=\"page-break-after: always\"></div>

|           | device - Other variation                                                                        |            |            |                                  |                                                                              |
|-----------|-------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------|
| IAIN/0001 | A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs | 16/07/2021 | 22/07/2022 | SmPC, Annex II, Labelling and PL | To change the invented name of the medicinal product from Kixelle to Kirsty. |